These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 23781140)

  • 1. Enrichment of prostate cancer stem-like cells from human prostate cancer cell lines by culture in serum-free medium and chemoradiotherapy.
    Wang L; Huang X; Zheng X; Wang X; Li S; Zhang L; Yang Z; Xia Z
    Int J Biol Sci; 2013; 9(5):472-9. PubMed ID: 23781140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer.
    Wang C; Xie J; Guo J; Manning HC; Gore JC; Guo N
    Oncol Rep; 2012 Oct; 28(4):1301-8. PubMed ID: 22895640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma.
    Kim MP; Fleming JB; Wang H; Abbruzzese JL; Choi W; Kopetz S; McConkey DJ; Evans DB; Gallick GE
    PLoS One; 2011; 6(6):e20636. PubMed ID: 21695188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation, Culture and Identification of Choriocarcinoma Stem-Like Cells from the Human Choriocarcinoma Cell-Line JEG-3.
    Cai J; Peng T; Wang J; Zhang J; Hu H; Tang D; Chu C; Yang T; Liu H
    Cell Physiol Biochem; 2016; 39(4):1421-32. PubMed ID: 27606814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer stem-like cells in human prostate carcinoma cells DU145: the seeds of the cell line?
    Wei C; Guomin W; Yujun L; Ruizhe Q
    Cancer Biol Ther; 2007 May; 6(5):763-8. PubMed ID: 17592251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD133+, CD166+CD44+, and CD24+CD44+ phenotypes fail to reliably identify cell populations with cancer stem cell functional features in established human colorectal cancer cell lines.
    Muraro MG; Mele V; Däster S; Han J; Heberer M; Cesare Spagnoli G; Iezzi G
    Stem Cells Transl Med; 2012 Aug; 1(8):592-603. PubMed ID: 23197865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly enriched CD133(+)CD44(+) stem-like cells with CD133(+)CD44(high) metastatic subset in HCT116 colon cancer cells.
    Chen KL; Pan F; Jiang H; Chen JF; Pei L; Xie FW; Liang HJ
    Clin Exp Metastasis; 2011 Dec; 28(8):751-63. PubMed ID: 21750907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pristimerin Inhibits Prostate Cancer Bone Metastasis by Targeting PC-3 Stem Cell Characteristics and VEGF-Induced Vasculogenesis of BM-EPCs.
    Huang S; He P; Peng X; Li J; Xu D; Tang Y
    Cell Physiol Biochem; 2015; 37(1):253-68. PubMed ID: 26302893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumorspheres derived from prostate cancer cells possess chemoresistant and cancer stem cell properties.
    Zhang L; Jiao M; Li L; Wu D; Wu K; Li X; Zhu G; Dang Q; Wang X; Hsieh JT; He D
    J Cancer Res Clin Oncol; 2012 Apr; 138(4):675-86. PubMed ID: 22237455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of CD44(high)/CD133(high) HCT-116 cells in the tumorigenesis of colon cancer.
    Zhou JY; Chen M; Ma L; Wang X; Chen YG; Liu SL
    Oncotarget; 2016 Feb; 7(7):7657-66. PubMed ID: 26840024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic cancer cells resistant to chemoradiotherapy rich in "stem-cell-like" tumor cells.
    Du Z; Qin R; Wei C; Wang M; Shi C; Tian R; Peng C
    Dig Dis Sci; 2011 Mar; 56(3):741-50. PubMed ID: 20683663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of cancer stem cells from human glioblastomas: growth and differentiation capabilities and CD133/prominin-1 expression.
    Gambelli F; Sasdelli F; Manini I; Gambarana C; Oliveri G; Miracco C; Sorrentino V
    Cell Biol Int; 2012 Jan; 36(1):29-38. PubMed ID: 21916848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties.
    Leung EL; Fiscus RR; Tung JW; Tin VP; Cheng LC; Sihoe AD; Fink LM; Ma Y; Wong MP
    PLoS One; 2010 Nov; 5(11):e14062. PubMed ID: 21124918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Side population rather than CD133(+) cells distinguishes enriched tumorigenicity in hTERT-immortalized primary prostate cancer cells.
    Zhou J; Wang H; Cannon V; Wolcott KM; Song H; Yates C
    Mol Cancer; 2011 Sep; 10():112. PubMed ID: 21917149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation-induced glucocorticoid receptor promotes CD44+ prostate cancer stem cell growth through activation of SGK1-Wnt/β-catenin signaling.
    Chen F; Chen X; Ren Y; Weng G; Keng PC; Chen Y; Lee SO
    J Mol Med (Berl); 2019 Aug; 97(8):1169-1182. PubMed ID: 31187175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cultivation and identification of colon cancer stem cell-derived spheres from the Colo205 cell line.
    Li YF; Xiao B; Tu SF; Wang YY; Zhang XL
    Braz J Med Biol Res; 2012 Mar; 45(3):197-204. PubMed ID: 22310487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic cancer stem-like cells display aggressive behavior mediated via activation of FoxQ1.
    Bao B; Azmi AS; Aboukameel A; Ahmad A; Bolling-Fischer A; Sethi S; Ali S; Li Y; Kong D; Banerjee S; Back J; Sarkar FH
    J Biol Chem; 2014 May; 289(21):14520-33. PubMed ID: 24719318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD49f is an efficient marker of monolayer- and spheroid colony-forming cells of the benign and malignant human prostate.
    Yamamoto H; Masters JR; Dasgupta P; Chandra A; Popert R; Freeman A; Ahmed A
    PLoS One; 2012; 7(10):e46979. PubMed ID: 23071686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microenvironmentally-driven Plasticity of CD44 isoform expression determines Engraftment and Stem-like Phenotype in CRC cell lines.
    Dinger TF; Chen O; Dittfeld C; Hetze L; Hüther M; Wondrak M; Löck S; Eicheler W; Breier G; Kunz-Schughart LA
    Theranostics; 2020; 10(17):7599-7621. PubMed ID: 32685007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers.
    Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY
    Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.